OBJECTIVES: We evaluated the association between TH use and "dose" and cumulative vasopressor and inotrope requirement, survival, and neurologic outcome. BACKGROUND: Therapeutic hypothermia (TH) improves outcome after cardiac arrest, but may increase vasopressor and inotrope requirements. METHODS: Chart review of in- and out-of-hospital cardiac arrests between 1/1/2005 and 3/15/2010. Data included demographic information, category of post-cardiac arrest illness severity ((I) awake, (II) coma (not following commands but intact brainstem responses)+mild cardiopulmonary dysfunction (SOFA [Sequential Organ Failure Assessment] cardiac+respiratory score<4), (III) coma+moderate-severe cardiopulmonary dysfunction (SOFA cardiac+respiratory score≥4), and (IV) coma without brainstem reflexes), cumulative vasopressor index (CVI), inotrope use, survival, and neurologic outcome. The "dose" of TH (hours*temperature below threshold) was calculated using thresholds of ≤34 °C and ≤35 °C. Data were analyzed using descriptive statistics, Student's t-test, Wilcoxon test, and chi-squared analysis. Linear and logistic regression evaluated the effect of hypothermia "dose" on total CVI, survival and neurologic outcome. RESULTS: Among 361 comatose patients, 233 (65%) received TH. Vasopressor administration (measured by CVI) was higher in normothermic subjects (60.2% vs. 46.4%; p=0.016). Using a 34 °C threshold, SOFA respiratory subscore and PEA arrest predicted total CVI. Using a 35 °C threshold, severity of coma, SOFA respiratory subscore, PEA arrest and use of inotropic agents in addition to vasopressors predicted total CVI. Initial motor examination predicted survival and neurologic outcome, while TH "dose" did not. CONCLUSIONS: TH delivery is not associated with vasopressor requirement. TH "dose" is not associated with total CVI, survival, or good outcome. Vasopressor or inotropic requirement should not contraindicate TH use.
OBJECTIVES: We evaluated the association between TH use and "dose" and cumulative vasopressor and inotrope requirement, survival, and neurologic outcome. BACKGROUND: Therapeutic hypothermia (TH) improves outcome after cardiac arrest, but may increase vasopressor and inotrope requirements. METHODS: Chart review of in- and out-of-hospital cardiac arrests between 1/1/2005 and 3/15/2010. Data included demographic information, category of post-cardiac arrest illness severity ((I) awake, (II) coma (not following commands but intact brainstem responses)+mild cardiopulmonary dysfunction (SOFA [Sequential Organ Failure Assessment] cardiac+respiratory score<4), (III) coma+moderate-severe cardiopulmonary dysfunction (SOFA cardiac+respiratory score≥4), and (IV) coma without brainstem reflexes), cumulative vasopressor index (CVI), inotrope use, survival, and neurologic outcome. The "dose" of TH (hours*temperature below threshold) was calculated using thresholds of ≤34 °C and ≤35 °C. Data were analyzed using descriptive statistics, Student's t-test, Wilcoxon test, and chi-squared analysis. Linear and logistic regression evaluated the effect of hypothermia "dose" on total CVI, survival and neurologic outcome. RESULTS: Among 361 comatosepatients, 233 (65%) received TH. Vasopressor administration (measured by CVI) was higher in normothermic subjects (60.2% vs. 46.4%; p=0.016). Using a 34 °C threshold, SOFA respiratory subscore and PEA arrest predicted total CVI. Using a 35 °C threshold, severity of coma, SOFA respiratory subscore, PEA arrest and use of inotropic agents in addition to vasopressors predicted total CVI. Initial motor examination predicted survival and neurologic outcome, while TH "dose" did not. CONCLUSIONS: TH delivery is not associated with vasopressor requirement. TH "dose" is not associated with total CVI, survival, or good outcome. Vasopressor or inotropic requirement should not contraindicate TH use.
Authors: Benjamin S Abella; James W Rhee; Kuang-Ning Huang; Terry L Vanden Hoek; Lance B Becker Journal: Resuscitation Date: 2005-02 Impact factor: 5.262
Authors: Raina M Merchant; Jasmeet Soar; Markus B Skrifvars; Tom Silfvast; Dana P Edelson; Fawaz Ahmad; Kuang-Ning Huang; Monica Khan; Terry L Vanden Hoek; Lance B Becker; Benjamin S Abella Journal: Crit Care Med Date: 2006-07 Impact factor: 7.598
Authors: Sebastian Wolfrum; Peter W Radke; Tobias Pischon; Stefan N Willich; Heribert Schunkert; Volkhard Kurowski Journal: Resuscitation Date: 2006-11-13 Impact factor: 5.262
Authors: J L Vincent; R Moreno; J Takala; S Willatts; A De Mendonça; H Bruining; C K Reinhart; P M Suter; L G Thijs Journal: Intensive Care Med Date: 1996-07 Impact factor: 17.440
Authors: A H Idris; L B Becker; J P Ornato; J R Hedges; N G Bircher; N C Chandra; R O Cummins; W Dick; U Ebmeyer; H R Halperin; M F Hazinski; R E Kerber; K B Kern; P Safar; P A Steen; M M Swindle; J E Tsitlik; I von Planta; M von Planta; R L Wears; M H Weil Journal: Circulation Date: 1996-11-01 Impact factor: 29.690
Authors: Manuel Ruiz-Bailén; Eduardo Aguayo de Hoyos; Silvia Ruiz-Navarro; Miguel Angel Díaz-Castellanos; Luis Rucabado-Aguilar; Francisco Javier Gómez-Jiménez; Sergio Martínez-Escobar; Rafael Melgares Moreno; Javier Fierro-Rosón Journal: Resuscitation Date: 2005-08 Impact factor: 5.262
Authors: Patrick J Coppler; Jonathan Elmer; Luis Calderon; Alexa Sabedra; Ankur A Doshi; Clifton W Callaway; Jon C Rittenberger; Cameron Dezfulian Journal: Resuscitation Date: 2015-01-28 Impact factor: 5.262
Authors: Xue-Han Ning; Outi M Villet; Ming Ge; Laigam N Sekhar; Marshall A Corson; Tracy S Tylee; Lu-Ping Fan; Lin Yao; Chun Zhu; Aaron K Olson; Norman E Buroker; Cheng-Su Xu; David L Anderson; Yong-Kian Soh; Elise Wang; Shi-Han Chen; Michael A Portman Journal: Ther Hypothermia Temp Manag Date: 2014-12-16 Impact factor: 1.286